![David Mott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Mott
Chairman at
ARDELYX, INC.
Net worth: 21 M $ as of 30/05/2026
Profile
David M.
Mott was the founder of MedImmune Ventures, Inc., founded in 2002, where the title held was President from 2002 to 2008.
Current jobs include Chairman at Ardelyx, Inc. since 2014, Chairman at Cydan LLC, Independent Director at Novavax, Inc. since 2020, Director at Biotechnology Innovation Organization, Director at NEA 14 GP Ltd., and Director at XTuit Pharmaceuticals, Inc. Former jobs include Vice Chairman, President & Chief Executive Officer at MedImmune LLC from 2004 to 2008; President & Chief Executive Officer at MedImmune Ltd. from 2000 to 2008; Chairman-Supervisory Board at Prosensa Holding NV from 2014 to 2015; Chairman at Epizyme, Inc. from 2016 to 2022; Chairman at Mersana Therapeutics, Inc. from 2015 to 2026; Chairman at Adaptimmune Therapeutics Plc from 2017 to 2025; Chairman at Imara, Inc. from 2016 to 2023; Non-Executive Director at Shire Plc from 2007 to 2009; Independent Director at Omthera Pharmaceuticals, Inc. in 2013; Director at Tesaro, Inc. from 2010 to 2019; Independent Director at Clementia Pharmaceuticals, Inc. from 2015 to 2018; Independent Non-Executive Director at Nightstar Therapeutics Ltd. from 2015 to 2019; Director at Tiburio Therapeutics, Inc. from 2018 to 2020; Executive Vice President at AstraZeneca PLC from 2007 to 2008; General Partner at NEA Management Co. LLC from 2008 to 2020; Vice President-Health Care Investment Banking at Smith Barney Harris Upham & Co., Inc. from 1986 to 1992; General Partner at New Enterprise Associates LLC from 2008 to 2020.
Education includes an undergraduate degree from Dartmouth College, conferred in 1986.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARDELYX, INC. 1.36% | 15/06/2026 | 3,349,655 ( 1.36% ) | 20 M $ | 30/05/2026 |
NOVAVAX, INC. 0.05% | 19/06/2026 | 79,770 ( 0.05% ) | 875 077 $ | 30/05/2026 |
| 10/04/2025 | 0 ( -.--% ) | - $ | 30/05/2026 | |
| 05/01/2026 | 0 ( -.--% ) | - $ | 30/12/2025 |
David Mott active positions
| Companies | Position | Start |
|---|---|---|
| ARDELYX, INC. | Chairman | 28/02/2014 |
| NOVAVAX, INC. | Director/Board Member | 15/06/2020 |
Cydan LLC
 Cydan LLC Medical DistributorsDistribution Services Operates as an orphan drug accelerator that identifies and de-risks programs | Chairman | - |
NEA 14 GP Ltd. | Director/Board Member | - |
XTuit Pharmaceuticals, Inc.
 XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Director/Board Member | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
Former positions of David Mott
| Companies | Position | End |
|---|---|---|
| MERSANA THERAPEUTICS | Chief Executive Officer | 01/03/2015 |
| ADAPTIMMUNE THERAPEUTICS PLC | Chairman | 13/11/2025 |
| IMARA | Chairman | 31/01/2023 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Training of David Mott
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
45
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 45 |
|---|---|
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Conceptis Technologies, Inc.
 Conceptis Technologies, Inc. Internet Software/ServicesTechnology Services Provides online and offline medical education and promotion aimed at physicians | Technology Services |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures invests in private biotechnology companies located across the globe primarily in North America. The firm focuses on healthcare sectors such as molecules, vaccines, pharmaceutical technologies, medical devices, diagnostics, imaging and healthcare IT. The firm provides financing for seed, early, later and mezzanine stage capital requirements with an investment size ranging from USD 5 - USD 10 million per round. It acts as a lead investor and takes an active role on the board of directors. | Finance |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Smith Barney Harris Upham & Co., Inc.
 Smith Barney Harris Upham & Co., Inc. Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
St. James' School
 St. James' School Other Consumer ServicesConsumer Services Operates an all girls' school | Consumer Services |
Harris Upham & Co, Inc.
 Harris Upham & Co, Inc. Investment Banks/BrokersFinance Security Broker | Finance |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Health Technology |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Health Services |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on discovering and developing therapies for the treatment inflammatory and metabolic diseases | Health Technology |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that specializes in the systemic administration of therapeutics | Health Technology |
St. Albans School
 St. Albans School Other Consumer ServicesConsumer Services Operates boarding schools | Consumer Services |
NEA 14 GP Ltd. | |
XTuit Pharmaceuticals, Inc.
XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Develops and commercializes drugs | Health Technology |
Cydan LLC
Cydan LLC Medical DistributorsDistribution Services Operates as an orphan drug accelerator that identifies and de-risks programs | Distribution Services |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Finance |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases | Health Technology |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Engages in pre-clinical and clinical studies and develops drugs for patients suffering from diseases | Health Technology |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Polyneuron Pharmaceuticals AG
 Polyneuron Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of autoimmune disorders | Health Technology |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance Operates as a venture capital firm | Finance |
Tiburio Therapeutics, Inc.
 Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnological research and developmental services | Health Technology |
- Stock Market
- Insiders
- David Mott
Choose MarketScreener 
